نتایج جستجو برای: factor v inhibitor

تعداد نتایج: 1288426  

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تربیت مدرس - دانشکده علوم پزشکی 1391

مطالعات انجام شده روی مکانیسمهای تکوینی و تکاملی گلبولهای قرمز منجر به دستیابی بشر به مفاهیم پایه و مهمی در ارتباط با مکانیسمهای عمومی تنظیم بیان ژن وشکل گیری بافتها شده است. تمایز اختصاصی به رده ارتیروئید و هر رده دیگری، شدیداً وابسته به تنظیم در سطح بیان ژن و فاکتورهای کنترلی خاص نظیر سیتوکین ها، فاکتورهای نسخه برداری ویژه، عناصر کنترل کننده چرخه سلولی، تکثیر،آپوپتوز و عناصر سیگنالینگ داخل سلو...

ALlAKBAR POURFATHOLLAh, HABffiOLLAHE SMAILI, HASSAN MANSOURI TORGHABEH, MAHMOOD MAHMOOD IAN SHOOSHTARI, ZAHRA REZAIE-YAZD,

Journal: :Hong Kong medical journal = Xianggang yi xue za zhi 2015
Anne K H Leung George W Y Ng K C Sin S Y Au K Y Lai K L Lee K I Law

We report a rare complication of factor V deficiency in a patient having Legionella pneumonia. This patient also had other complications like severe acute respiratory distress syndrome, acute kidney injury, and septic shock that required venous-venous extracorporeal membrane oxygenation support. This is the first reported case of acquired factor V deficiency in a patient receiving extracorporea...

Faranoush , Mohammad , Karimi , Katayoun , Managhchi , Mohammad-Reza , Rezaiei–Hemami , Mohsen , Roushan , Nader , Toogeh , Gholamreza , Zarrabi , Fariba ,

Background: The development of inhibitors is a complication factor replacement therapy in hereditary factor VIII deficiency. Several management options are available for the treatment of inhibitor. Rituximab, a monoclonal antibody against CD20, reduces inhibitor level in rare bleeding disorders. The aim of this study was to evaluate the effectiveness of rituximab in lowering or eliminating the ...

Journal: :iranian journal of neurology 0
ehsan kheradmand neurosciences research center, department of neurology, alzahra hospital, isfahan university of medical sciences, isfahan, iran shaghayegh haghjooy-javanmard applied physiology research center, isfahan university of medical sciences, isfahan, iran leila dehghani school of advanced technologies in medicine, shahid beheshti university of medical sciences, tehran and neurosciences research center, department of neurology, alzahra hospital, isfahan university of medical sciences, isfahan iran mohammad saadatnia neurosciences research center, department of neurology, alzahra hospital, isfahan university of medical sciences, isfahan, iran

introduction : activated protein c (apc) inactivates factor v by cleavage of its heavy chain at arg306, arg506, arg679, and lys994. mutational changes, which abolish apc cleavage sites, may predispose thrombosis by altering the inactivation process of factor v.  factor v leiden (arg506glu) has been demonstrated as a strong risk factor for thrombosis. in the current study, we have studied whethe...

Journal: :The Journal of clinical investigation 1988
G M Rodgers W H Kane R E Pitas

Vascular cell procoagulant activity may be important in the pathogenesis of atherosclerosis. In previous studies, we described the ability of the atherogenic metabolite homocysteine to activate endothelial cell Factor V, a key coagulation cofactor for thrombin generation. The present study was designed to investigate Factor V activity and Factor Xa-catalyzed prothrombin activation by control an...

Journal: :iranian journal of blood and cancer 0
m payandeh medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) n amirifard cancer research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) e sadeghi medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) m sadeghi medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) m choubsaz cancer research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) f noor mohammadi far medical biology research center, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences)

background: hemophilia is the most frequent severe hereditary hemorrhagic disease due to deficiency of coagulation factors viii (hemophilia a) or ix (hemophilia b) in plasma. we aimed to identify patients with hemophilia in kermanshah, iran and assess the incidence of inhibitors in this population and its associated factors. methods: this study was conducted on patients with hemophilia a and b ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید